Lipid metabolism during the perinatal phase, and its implications on postnatal development

E Herrera1, I López-Soldado, M Limones

  • 1Facultad de Ciencias Experimentales y de la Salud, Universidad San Pablo-CEU, Madrid, Spain. eherrera@ceu.es

Insights

Maternal lipid metabolism during pregnancy impacts offspring development. Undernutrition and altered food intake during lactation have long-term effects on glucose regulation, outweighing dietary fatty acid composition changes.

Area of Science:

  • Perinatal nutrition and metabolism
  • Developmental programming
  • Endocrinology

Background:

  • Lipid metabolism is crucial during pregnancy for fetal substrate supply.
  • Perinatal nutritional insults can have lasting effects on offspring health.
  • Understanding these effects is key to preventing metabolic disorders.

Purpose of the Study:

  • To investigate the short- and long-term effects of altered maternal lipid metabolism during the perinatal stage on offspring.
  • To determine the impact of maternal fat accumulation, undernutrition, and omega-3 fatty acid intake on offspring development and glucose homeostasis.
  • To elucidate the mechanisms behind long-term metabolic consequences, differentiating between dietary composition and food intake effects.

Main Methods:

  • Experimental designs in rats to manipulate maternal nutrition during specific perinatal periods (pregnancy, lactation).
  • Assessment of intrauterine development, postnatal growth, body weight, and food intake.
  • Evaluation of offspring glucose tolerance and glucose/insulin relationships at adult ages (10 and 16 weeks).
  • Cross-fostering experiments to distinguish between prenatal and lactational effects.
  • Investigation into the roles of decreased food intake versus altered milk composition.

Main Results:

  • Impeded maternal fat accumulation in early pregnancy restricted intrauterine growth and impaired adult glucose tolerance.
  • Undernutrition during suckling led to decreased body weight with lasting effects, despite normal post-weaning intake.
  • A diet rich in omega-3 fatty acids during lactation, not pregnancy, negatively affected offspring glucose/insulin relationships.
  • Reduced food intake during lactation, caused by the omega-3 rich diet, was responsible for altered pancreatic glucose responsiveness, not changes in milk fatty acid composition.

Conclusions:

  • Maternal fat accumulation during early pregnancy is critical for normal intrauterine development and long-term metabolic health.
  • Food intake during the lactation period significantly influences postnatal development and adult glucose/insulin regulation.
  • The impact of maternal nutrition on offspring metabolic programming is complex, with factors like food availability playing a more dominant role than specific dietary components like omega-3 fatty acids.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Overview of Fatty Acid Metabolism01:28

Overview of Fatty Acid Metabolism

Lipids also are sources of energy that power cellular processes. Like carbohydrates, lipids are composed of carbon, hydrogen, and oxygen, but these atoms are arranged differently. Most lipids are nonpolar and hydrophobic. Major types include fats and oils, waxes, phospholipids, and steroids.
Fatty acids are catabolized in a process called beta-oxidation, which takes place in the matrix of the mitochondria and converts their fatty acid chains into two-carbon units of acetyl groups. The acetyl...
Lipid-derived Compounds in the Human Body01:31

Lipid-derived Compounds in the Human Body

Fats and lipids are crucial components in the human body. Some lipid-derived compounds, such as fat-soluble vitamins, eicosanoids, lipoproteins, and glycolipids, also play unique roles to support various  biological processes .
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin, delayed...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...